Viewing Study NCT02965092


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-03 @ 1:18 AM
Study NCT ID: NCT02965092
Status: UNKNOWN
Last Update Posted: 2019-05-10
First Post: 2016-11-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Sponsor: Wuhan Sian Medical Technology Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module